Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)

v3.21.1
Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Totals 6,496,261 3,465,485
Options to Purchase Common Stock [Member]    
Totals 1,920,269 996,645
Unvested Restricted stock [Member]    
Totals 1,072,503  
Series H-1, H-3, H-4, H-5, I, J, pre-merger AYRO and Merger Common Stock Purchase Warrants [Member]    
Totals 3,501,014 461,647
Series H, H-3, H-6, and Pre-merger AYRO Seed Preferred Stock [Member]    
Totals 2,475 2,007,193
Unvested restricted stock [Member]    
Totals